Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
R926112 in Seasonal Allergic Rhinitis
NCT00115089Phase 2Completed
- Sponsor
- Rigel Pharmaceuticals, Inc.
- Start
- Jul 2005
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of R112 in seasonal allergic rhinitis (SAR), sponsored by Rigel Pharmaceuticals, Inc.. Started Jul 2005; status: completed.
02
Drugs
R112
03
Conditions
seasonal allergic rhinitis (SAR)
Beyond the preview
Go deeper on NCT00115089.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00115089.